Ośrodkowo generowane zaburzenia motoryczne

Jeffrey P. Okeson

Streszczenia

 Liczne czynniki, które mogą oddziaływać na mięśnie układu ruchowego narządu żucia, są albo pod silnym wpływem OUN, albo faktycznie generowane przez niego. Czynniki te obejmują bruksizm nocny, zaciskanie zębów w ciągu dnia, dystonie ustno-żuchwowe. Bruksizm i zaciskanie zębów zostały określone w tym tekście jako aktywności parafunkcjonalne, które wywołują nadmierną aktywność mięśni. Zaburzenia te są powszechnie spotykane w gabinecie stomatologicznym. Dystonia ustno-żuchwowa, chociaż nie występuje tak często, musi być rozpoznana przez lekarza, aby pacjent cierpiący na to wyniszczające schorzenie mógł być właściwie leczony. Zasadą, z której należy zdawać sobie sprawę, jest to, że przyczyny tych zaburzeń mają swój początek w OUN, dlatego leczenie ich jest bardzo trudne i w niektórych przypadkach niemożliwe. Stąd strategie leczenia są często leczeniem wspomagającym

PIŚMIENNICTWO

1. Wu YL, Chang LY, Lee HC i wsp. Sleep distrurbances in fibromyal­gia: a meta-analysis of case-conrol studies. J Psychosom Res. 2017; 96: 89-97.
2. Alves B, Zakka TM, Teixeira MJ i wsp. Depression, sexuality and fibro­myalgia syndrome: clinical fi ndings and correlation to hematological parameters. Arq Neuropsiquiatr. 2016; 74(11): 863-868.
3. Bennett RM, Friend R, Marcus D i wsp. Criteria for the diagnosis of fi­bromyalgia: validation of the modified 2010 preliminary american col­lege of rheumatology criteria and the development of alternative crite­ria. Arthritis Care Res (Hoboken). 2014; 66(9): 1364-1373.
4. Bennett RB, Campbell S, Burckhardt C i wsp. A multidisciplinary ap­proach to fibromyalgia management. J Musculoskel Med. 1991; 8: 21.
5. Affaitati G, Costantini R, Fabrizio A i wsp. Effects of treatment of peri­pheral pain generators in fibromyalgia patients. Eur J Pain. 2011; 11(6): 516-527.
6. Arnold L, Mease P, Silverman S. Pregabalin: an alpha2-delta (alpha­2-delta) ligand for the management of fibromyalgia. Am J Managed Care. 2010; 16(Suppl 5): S138-S143.
7. Emir B, Murphy TK, Petersel DL i wsp. Treatment response to pregaba­lin in fibromyalgia pain: effect of patient baseline characteristics. Exp Opin Pharmacother. 2010; 11(14): 2275-2280.
8. Roskell NS, Beard SM, Zhao Y i wsp. A meta-analysis of pain respon­se in the treatment of fi bromyalgia. Pain Pract. 2011; 15(1): 61-69.
9. Tzellos TG, Toulis KA, Goulis DG i wsp. Gabapentin and pregabalin in the treatment of fibromyalgia: a systematic review and a meta-analy­sis. J Clin Pharm Ther. 2010; 35(6): 639-656.
10. Silverman SL, Backonja M, Pauer L i wsp. Effect of baseline characte­ristics on the response to pregabalin in fibromyalgia patients with co­morbid depression. Pain Med. 2018; 19(3): 419-428.
11. Kim SC, Landon JE, Solomon DH. Clinical characteristics and medi­cation uses among fibromyalgia patients newly prescribed amitripty­line, duloxetine, gabapentin, or pregabalin. Arthritis Care Res (Hobo­ken). 2013; 65(11): 1813-1819.
12. Ang DC, Kaleth AS, Bigatti S i wsp. Research to Encourage Exercise for Fibromyalgia (REEF): use of motivational interviewing design and me­thod. Contemp Clin Trials. 2011; 32(1): 59-68.
13. Pierce CJ, Gale EN. A comparison of diff erent treatments for noctur­nal Bruxism. J Dent Res. 1988; 67(3): 597-601.
14. Solberg WK, Clark GT, Rugh JD. Nocturnal electromyographic evalu¬ation of bruxism patients undergoing short term splint therapy. J Oral Rehabil.1975; 2(3): 215-223.
15. Gowans SE. Fibromyalgia: increased regular physical activity as “exer¬cise” in fibromyalgia. Nat Rev Rheumatol. 2010; 6(9): 499-500.
16. Hauser W, Klose P, Langhorst J i wsp. Efficacy of different types of ae¬robic exercise in fibromyalgia syndrome: a systematic review and me¬ta-analysis of randomised controlled trials. Arthritis Res Ther. 2010; 12(3): R79.
17. Mannerkorpi K, Nordeman L, Cider A i wsp. Does moderate- to-high intensity Nordic walking improve functional capacity and pain in fi¬bromyalgia? A prospective randomized controlled trial. Arthritis Res Ther. 2010; 12(5): R189.
18. Sanudo B, Galiano D, Carrasco L i wsp. Aerobic exercise versus com¬bined exercise therapy in women with fibromyalgia syndrome: a ran¬domized controlled trial. Arch Phys Med Rehabil. 2010; 91(12): 1838- 1843.
19. Bidonde J, Bush AJ, Schachter CL i wsp. Aerobic exercise training for adults with fibromyalgia. Cochrane Database Syst Rev. 2017; 6: CD012700.
20. Del Pozo-Cruz J, Alfonso-Rosa RM, Castillo-Cuerva A i wsp. Depres¬sion symptoms are associated with key health outcomes in women with fibromyalgia: a cross-sectional study. Int J Rheum Dis. 2017; 20(7): 798-808.
21. Granges G, Littlejohn GO. A comparative study of clinical signs in fibro¬myalgia/fibrositis syndrome, healthy and exercising subjects. J Rheu¬matol. 1993; 20: 344-351.
22. Ramfjord SP. Dysfunctional temporomandibular joint and musclem¬pain. J Prosthet Dent. 1961; 11: 353-362.
23. Turk DC, Zaki HS, Rudy TE: Eff ects of intraoral appliance and bio¬feedback/ stress management alone and in combination in treating pain and depression in patients with temporomandibular disorders. J Prosthet Dent. 1993; 70(2): 158-164.
24. Ramfjord S. Bruxism: a clinical and electromyographic study. J Am Dent Assoc. 1961; 62: 21-28.
25. Arnold M. Bruxism and the occlusion. Dent Clin North Am. 1981; 25(3): 395-407.
26. Ramfjord SP, Ash MM. Occlusion. Philadelphia; 1983.
27. Graf H. Bruxism. Dent Clin North Am. 1969; 13(3): 659-665.
28. Shore NA. Occlusal Equilibration and Temporomandibular Joint Dys¬function. Philadelphia; 1959: 352-359.
29. Posselt U. The temporomandibular joint syndrome and occlusion. J Prosthet Dent. 1971; 25(4): 432-438.
30. Rugh JD, Barghi N, Drago CJ. Experimental occlusal discrepancies and nocturnal bruxism. J Prosthet Dentist. 1984; 51(4): 548-553.
31. Bailey JO, Rugh JD. Effects of occlusal adjustment on bruxism as mo¬nitored by nocturnal EMG recordings. J Dent Res. 1980; 59: 317. (spe¬cial issue).
32. Rugh JD, Solberg WK. Electromyographic studies of bruxist behavior before and during treatment. J Calif Dent Assoc. 1975; 3(9): 56-59.
33. Solberg WK, Flint RT, Brantner JP. Temporomandibular joint pain and dysfunction: a clinical study of emotional and occlusal components. J Prosthet Dentist. 1972; 28(4): 412-422.
34. Bertazzo-Silveira E, Kruger CM, Porto De Toledo I i wsp. Association between sleep bruxism and alcohol, caffeine, tobacco, and drug abuse: a systematic review. J Am Dent Assoc. 2016; 147(11): 859-866.
35. Franks AST. Conservative treatment of temporomandibular joint dys¬function: a comparative study. Dent Pract Dent Rec. 1965; 15: 205-210.
36. Okeson JP, Moody PM, Kemper JT i wsp. Evaluation of occlusal splint therapy and relaxation procedures in patients with temporomandibu¬lar disorders. J Am Dent Assoc. 1983; 107(3): 420-424.
37. Okeson JP, Kemper JT, Moody PM. A study of the use of occlusion splints in the treatment of acute and chronic patients with cranioman¬dibular disorders. J Prosthet Dent. 1982; 48(6): 708-712.
38. Okeson JP. Th e eff ects of hard and soft occlusal splints on nocturnal bruxism. J Am Dent Assoc. 1987; 114(6): 788-791.
39. Fuchs P. Th e muscular activity of the chewing apparatus during night sleep. An examination of healthy subjects and patients with functio¬nal disturbances. J Oral Rehabil. 1975; 2(1): 35-48.
40. Sheikholeslam A, Holmgren K, Riise C. A clinical and electromy¬ographic study of the long-term effects of an occlusal splint on the temporal and masseter muscles in patients with functional disorders and nocturnal bruxism. J Oral Rehabil. 1986; 13(2): 137-145.
41. Raphael KG, Janal MN, Sirois DA i wsp. Validity of self-reported sleep bruxism among myofascial temporomandibular disorder patients and controls. J Oral Rehabil. 2015; 42(10): 751-758.
42. Raphael KG, Sirois DA, Janal MN i wsp. Sleep bruxism and myofascial temporomandibular disorders: a laboratory-based polysommographic investigation. J Am Dent Assoc. 2012; 143(11): 1223-1231.
43. Lavigne GJ, Khoury S, Abe S, i wsp. Bruxism physiology and patho¬logy: an overview for clinicians. J Oral Rehabil. 2008; 35(7): 476-494.
44. Brandner CR, Warmington SA. Delayed onset muscle soreness and per¬ceived exertion following blood flow restriction exercise. J Strength Cond Res. 2017.
45. Delcour L, Dallaudiere B, Omoumi P i wsp. Delayed onset muscleso¬reness. JBR-BTR. 2014; 97(5): 313.
46. Tsukiyama Y, Baba K, Clark GT. An evidence-based assessment of occ¬lusal adjustment as a treatment for temporomandibular disorders. J Prosthet Dent. 2001; 86(1): 57-66.
47. Hiyama S, Ono T, Ishiwata Y i wsp. First night effect of an interocclu¬sal appliance on nocturnal masticatory muscle activity. J Oral Reha¬bil. 2003; 30(2): 139-145.
48. Matsumoto H, Tsukiyama Y, Kuwatsuru R i wsp. The effect of intermit¬tent use of occlusal splint devices on sleep bruxism: a 4-week observa¬tion with a portable electromyographic recordingdevice. J Oral Reha¬bil. 2015; 42(4): 251-258.
49. Saletu A, Parapatics S, Saletu B i wsp. On the pharmacotherapy of sle¬ep bruxism: placebo-controlled polysomnographic and psychometric studies with clonazepam. Neuropsychobiology. 2005; 51(4): 214-225.
50. Clarke NG, Townsend GC, Carey SE. Bruxing patterns in man during sleep. J Oral Rehabil. 1983; 11(2): 123-127.
51. Rizzatti-Barbosa CM, Nogueira MT, de Andrade ED i wsp. Clinical eva¬luation of amitriptyline for the control of chronic pain caused by tem¬poromandibular joint disorders. Cranio. 2003; 21(3): 221-225.
52. Plesh O, Curtis D, Levine J i wsp. Amitriptyline treatment of chronic pain in patients with temporomandibular disorders. J Oral Rehabil. 2000; 27(10): 834-841.
53. Herman CR, Schiffman EL, Look JO i wsp. The effectiveness of adding pharmacologic treatment with clonazepam or cyclobenzaprine to pa¬tient education and self-care for the treatment of jaw pain upon awa¬kening: a randomized clinical trial. J Orofac Pain. 2002; 16(1): 64-70.
54. 54 Glaros AG, Williams K, Lausten L. The role of parafunctions, emotions and stress in predicting facial pain. J Am Dent Assoc. 2005; 136(4): 451-458.
55. Schmitter M, Kares-Vrincianu A, Kares H i wsp. Sleep-associated aspects of myofascial pain in the orofacial area among temporoman¬dibular disorder patients and controls. Sleep Med. 2015; 16(9): 1056- 1061.
56. Lavigne GJ, Sassle BJ. Th e neurobiology of orofacial pain and sleep and their interactions. J Dent Res. 2016; 95(10): 1109-1116.
57. Glaros AG, Forbes M, Shanker J i wsp. Effect of parafunctional clen¬ching on temporomandibular disorder pain and proprioceptive awa¬reness. Cranio. 2000; 18(3): 198-204.
58. Holmgren K, Sheikholeslam A, Riise C. Effect of a full-arch maxilla¬ry occlusal splint on parafunctional activity during sleep in patients with nocturnal bruxisn and signs and symptoms of craniomandibular disorders. J Prosthet Dent. 1993; 69: 293-297.
59. Carlson CR, Sherman JJ, Studts JL i wsp. The effects of tongue position on mandibular muscle activity. J Orofac Pain. 1997; 11(4):291-297.
60. Glaros AG, Kim-Weroha N, Lausten L i wsp. Comparison of habit rever¬sal and a behaviorally-modifi ed dental treatment for temporomandi¬bular disorders: a pilot investigation. Appl Psychophysiol Biofeedback. 2007; 32(3-4): 149-154.
61. Carlson C, Bertrand P, Ehrlich A i wsp. Physical self-regulation tra¬ining for the management of temporomandibular disorders. J Orofac Pain. 2001; 15: 47-55.
62. Anderson DM. Dorland’s Illustrated Medical Dictionary. Philadelphia; 1994.
63. Tolosa E, Marti MJ. Blepharospasm-oromandibular dystonia syndro¬me (Meige’s syndrome): clinical aspects. Adv Neurol. 1988; 49: 73-84.
64. Jankovic J. Etiology and diff erential diagnosis of blepharospasm and oromandibular dystonia. Adv Neurol. 1988; 49: 103-116.
65. Cardoso F, Jankovic J. Peripherally induced tremor and parkinsonism. Arch Neurol. 1995; 52(3): 263-270.
66. Miyaoka T, Miura S, Seno H i wsp. Jaw-opening dystonia (Brueghel’s syndrome) associated with cavum septi pellucidi and Verga’s ventric¬le: a case report. Eur J Neurol. 2003; 10(6): 727-729.
67. Nutt JG, Muenter MD, Aronson A i wsp. Epidemiology of focal and ge¬neralized dystonia in Rochester, Minnesota. Mov Disord. 1988; 3(3): 188-194.
68. Tan EK, Jankovic J. Botulinum toxin A in patients with oromandibu¬lar dystonia: long-term follow-up. Neurology. 1999; 53(9): 2102-2107.